Pharmaceutical industry regulation

FILE - In this Monday, March 2, 2020 file photo, Gilead Sciences CEO Daniel O'Day speaks at a meeting with President Donald Trump, members of the Coronavirus Task Force, and pharmaceutical executives in the Cabinet Room of the White House in Washington. Gilead, the pharmaceutical giant that makes remdesivir, a promising coronavirus drug, has registered it as a rare disease treatment with U.S. regulators on Monday, March 23, 2020, a status that can potentially be worth millions in tax breaks and competition-free sales. (AP Photo/Andrew Harnik)
1010 WINS Newsroom
March 24, 2020 - 9:11 pm
WASHINGTON (AP) — The pharmaceutical giant that makes a promising coronavirus drug has registered it as a rare disease treatment with U.S. regulators, a status that can potentially be worth millions in tax breaks and competition-free sales. What that specialty status will actually mean for the...
Read More
FILE - In this Dec. 24, 2019 photo, President Donald Trump speaks to members of the media following a Christmas Eve video teleconference with members of the military at his Mar-a-Lago estate in Palm Beach, Fla. As a candidate for the White House, Donald Trump repeatedly promised that he would “immediately” replace President Barack Obama’s health care law with a plan of his own that would provide “insurance for everybody.” Back then, Trump made it sound that his plan — “much less expensive and much better” than the Affordable Care Act — was imminent. And he put drug companies on notice that their pricing power no longer would be “politically protected.” Nearly three years after taking office, Americans still are waiting for Trump’s big reveal. (AP Photo/Andrew Harnik)
1010 WINS Newsroom
December 30, 2019 - 3:30 pm
WASHINGTON (AP) — As a candidate for the White House, Donald Trump repeatedly promised that he would “immediately” replace President Barack Obama’s health care law with a plan of his own that would provide “insurance for everybody.” Back then, Trump made it sound that his plan — “much less...
Read More
In this photo taken Tuesday, Nov. 5, 2019, palliative care nurse Madeleine Mukantagara, 56, left, prays with Vestine Uwizeyimana, 22, right, who has spinal degenerative disease and is taking oral liquid morphine for her pain, as she visits to check on her health at her home in the village of Bushekeli, near Kibogora, in western Rwanda. While people in rich countries are dying from overuse of prescription painkillers, people in Rwanda and other poor countries are suffering from a lack of them, but Rwanda has come up with a solution to its pain crisis - it's morphine, which costs just pennies to produce and is delivered to households across the country by public health workers. (AP Photo/Ben Curtis)
1010 WINS Newsroom
December 25, 2019 - 9:06 am
BUSHEKELI, Rwanda (AP) — It was something, the silence. Nothing but the puff of her breath and the scuff of her slip-on shoes as Madeleine Mukantagara walked through the fields to her first patient of the day. Piercing cries once echoed down the hill to the road below. What she carried in her bag...
Read More
FILE - In this July 17, 2019, file photo, a pack of Targin opioid pills made by Mundipharma is photographed in Sydney, Australia. Australia’s drug regulator has fined a pharmaceutical company owned by the billionaire Sackler family over what it dubbed misleading advertising for one of its opioid painkillers, as the country grapples with surging rates of opioid prescriptions and related deaths. Mundipharma Australia, the international affiliate of OxyContin maker Purdue Pharma, was ordered to pay penalties of 302,400 Australian dollars ($209,000) by the Therapeutic Goods Administration over its promotion of the opioid Targin, the drug regulator said in a statement. (AP Photo/David Goldman, File)
1010 WINS Newsroom
December 23, 2019 - 8:14 pm
SYDNEY (AP) — Australia’s drug regulator has fined a pharmaceutical company owned by the billionaire Sackler family over what it dubbed misleading advertising for one of its opioid painkillers, as the country grapples with surging rates of opioid prescriptions and related deaths. Mundipharma...
Read More
FILE - This June 15, 2018, file photo shows pharmaceuticals in North Andover, Mass. A revamped North American trade deal is nearing passage in Congress, giving both the White House and House Democrats cause to claim victory. There is relief, too, for farmers and businesses that wanted clearer rules governing the vast flow of goods among the United States, Canada and Mexico. But the pact left at least one surprising loser: The pharmaceutical industry, a near-invincible lobbying powerhouse in Washington. (AP Photo/Elise Amendola, File)
1010 WINS Newsroom
December 19, 2019 - 4:43 pm
A revamped North American trade deal nearing passage in Congress gives both the White House and Democrats a chance to claim victory and offers farmers and businesses clearer rules governing the vast flow of goods among the United States, Canada and Mexico. But the pact leaves at least one...
Read More
1010 WINS Newsroom
December 06, 2019 - 9:10 pm
WASHINGTON (AP) — A bipartisan Senate bill to curb prescription drug costs for Medicare recipients got a makeover Friday to lower copays and make it easier for seniors to budget for their expenses. The updated legislation unveiled by Sens. Chuck Grassley, R-Iowa, and Ron Wyden, D-Ore., would lower...
Read More
FILE - In this Wednesday, July 10, 2019, file photo, President Donald Trump speaks about kidney health, accompanied by Health and Human Services Secretary Alex Azar, left, in Washington. Azar says he and Trump are working on a plan to allow Americans to import lower-priced prescription drugs from Canada. (AP Photo/Alex Brandon, File)
July 31, 2019 - 6:26 pm
WASHINGTON (AP) — The Latest on President Donald Trump's plan to lower prescription drug prices (all times local): 6:20 p.m. It's unclear how soon consumers will see benefits from a Trump administration plan to allow Americans to legally and safely import lower-cost prescription drugs from Canada...
Read More
President Donald Trump speaks about kidney health at the Ronald Reagan Building and International Trade Center, accompanied by Health and Human Services Secretary Alex Azar, left, Wednesday, July 10, 2019, in Washington. (AP Photo/Alex Brandon)
July 11, 2019 - 6:08 pm
WASHINGTON (AP) — After two setbacks this week, President Donald Trump is now focusing his drive to curb drug costs on congressional efforts aimed at helping people on Medicare and younger generations covered by workplace plans. The White House on Thursday yanked its own regulation to ease the...
Read More
Judge Thad Balkman listens during opening arguments for the state of Oklahoma Tuesday, May 28, 2019, in Norman, Okla., as the nation's first state trial against drugmakers blamed for contributing to the opioid crisis begins in Oklahoma. At right is a slide from the state's presentation shown on a monitor. (AP Photo/Sue Ogrocki)
May 28, 2019 - 6:13 pm
NORMAN, Okla. (AP) — Corporate greed is responsible for an opioid crisis that has cost Oklahoma thousands of lives and will take billions of dollars to repair, the state's attorney general told a judge Tuesday at the start of the nation's first state trial against the companies accused of fueling...
Read More
FILE - In this March 13, 2019, file phtooHealth and Human Services Secretary Alex Azar testifies before a House Appropriations subcommittee on Capitol Hill in Washington. Azar says drugmakers will soon have to reveal prices of their prescription medicines in those ever-present TV ads. The Trump administration will issue final regulations on May 8 requiring drug companies to disclose list prices of medications costing more than $35 for a month’s supply. Azar tells The Associated Press if drugmakers are scared to put prices in ads that means they should lower those prices. (AP Photo/Susan Walsh, File)
May 08, 2019 - 7:44 pm
WASHINGTON (AP) — TV pitches for prescription drugs will soon include the price, giving consumers more information upfront as they make medication choices at a time when new drugs can carry anxiety-inducing prices. Health and Human Services Secretary Alex Azar said Wednesday the Trump...
Read More

Pages